Physician

Chathura Sankalpa Wijewardena, M.D

According to 2025 Medicare claims, Chathura Wijewardena, M.D (NPI: 1659807097) practices rheumatology in the Huntington-Ashland, WV-KY-OH market, with the plurality of this provider's patient population coming from Lawrence, OH. This provider's primary affiliated billing organization is KING'S DAUGHTERS MEDICAL SPECIALTIES, INC. (NPI: 1467982462; TIN: 264183569) and primary practice location at 41101-2876.

Wijewardena's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 283 traditional Medicare patients, billed 681 HCPCS/CPT codes, and received $38,401 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 2,759 prescription claims across 470 beneficiaries totaling $3,318,572 in drug costs, led by Enbrel Sureclick (Etanercept). Open Payments data shows 8 records totaling $166. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $2,408 to $3,318,572. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$21K$43K2022 Medicare payment: $13,602 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $42,984 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $38,401 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
202288163$13,602
2023276618$42,984
2024283681$38,401

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.7M$3.3M2019 Drug cost: $2,408 (USD; Tot_Drug_Cst)2020 Drug cost: $92,596 (USD; Tot_Drug_Cst)2021 Drug cost: $162,416 (USD; Tot_Drug_Cst)2022 Drug cost: $280,610 (USD; Tot_Drug_Cst)2023 Drug cost: $1,796,570 (USD; Tot_Drug_Cst)2024 Drug cost: $3,318,572 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
20191228$2,408
20203485$92,596
202170278$162,416
2022146491$280,610
20233761,747$1,796,570
20244702,759$3,318,572

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more8787$93
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more216440$62
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more3236$39

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Enbrel SureclickEtanercept1484,144$1,075,811
RinvoqUpadacitinib581,740$368,514
Xeljanz XrTofacitinib Citrate161,080$202,696
Humira(Cf) PenAdalimumab27812$197,847
Humira PenAdalimumab25756$171,997

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.8$166ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Chathura Sankalpa Wijewardena, M.D?

Tedicare shows public-source Medicare data for Chathura Sankalpa Wijewardena, M.D (NPI 1659807097), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Chathura Sankalpa Wijewardena, M.D have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Chathura Sankalpa Wijewardena, M.D?

Chathura Sankalpa Wijewardena, M.D is linked to KING'S DAUGHTERS MEDICAL SPECIALTIES, INC. (billing NPI 1467982462) in the available physician profile data.

Does Chathura Sankalpa Wijewardena, M.D have Open Payments data?

Chathura Sankalpa Wijewardena, M.D has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.